Regression of left ventricular hypertrophy in diabetics by a candesartan-based regimen in clinical practice.
Barrios
Vivencio
V
Escobar
Carlos
C
Calderón
Alberto
A
Vegazo
Onofre
O
Fernandez
Raúl
R
Asín
Enrique
E
D000368:Aged; D000959:Antihypertensive Agents / Q000627:therapeutic use; D001562:Benzimidazoles / Q000627:therapeutic use*; D001713:Biphenyl Compounds; D003924:Diabetes Mellitus, Type 2 / Q000150:complications* / Q000188:drug therapy; D004341:Drug Evaluation; D005260:Female; D006801:Humans; D006973:Hypertension / Q000188:drug therapy; D017379:Hypertrophy, Left Ventricular / Q000188:drug therapy*; D008297:Male; D008875:Middle Aged; D013777:Tetrazoles / Q000627:therapeutic use*
D000959:Antihypertensive Agents; D001562:Benzimidazoles; D001713:Biphenyl Compounds; D013777:Tetrazoles; C081643:candesartan